Camrelizumab
id:
camrelizumab-200-9411858
title:
Camrelizumab
text:
Camrelizumab (SHR-1210) (INN) is an anti-PD-1 immune checkpoint inhibitor that is being investigated for hepatocellular carcinoma and Hodgkin lymphoma. This drug is being developed by Jiangsu HengRui Medicine Co., Ltd. As of 2019, camrelizumab is undergoing Phase II/III trials.
brand slug:
wiki
category slug:
encyclopedia
description:
Pharmaceutical drug
original url:
https://en.wikipedia.org/wiki/Camrelizumab
date created:
date modified:
2023-11-30T20:06:25Z
main entity:
{"identifier":"Q60785565","url":"https://www.wikidata.org/entity/Q60785565"}
image:
fields total:
13
integrity:
14